Αποτελέσματα Αναζήτησης
27 Σεπ 2024 · Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by venous or arterial thrombosis and/or pregnancy morbidity in the presence of antiphospholipid antibodies (aPL) that persist over time.
STRENGTH:300 mcg/ml 4. CLINICALPARTICULARS: 4.1. Therapeutic Indication: Trinbelimab Injection is indicated to prevent Rh negative women from forming antibodies to foetal rhesus positive red blood cells, that may pass into the maternal during childbirth, abortion or certain other sensitizing events. 4.2. POSOLOGYAND METHOD OF ADMINISTRATION:
APLAs include anti-β2Glycoprotein I (anti-β2GPI), anticardiolipin (anti-CL) antibodies, and lupus anticoagulant. These antibodies are typical markers of antiphospholipid syndrome (APS) and are a part of its diagnostic criteria.
21 Αυγ 2024 · Patients may seek evaluation for symptoms or signs of primary infection (eg, chancre), secondary infection (eg, diffuse rash), or tertiary infection (eg, symptoms of aortic insufficiency). Alternatively, patients may be completely asymptomatic and only identified on routine screening.
24 Μαΐ 2018 · The antiphospholipid syndrome is a systemic autoimmune disease defined by thrombotic or obstetrical events that occur in patients with persistent antiphospholipid antibodies. 1 Thrombotic...
1 Ιουν 2023 · APLAs include anti-β2Glycoprotein I (anti-β2GPI), anticardiolipin (anti-CL) antibodies, and lupus anticoagulant. These antibodies are typical markers of antiphospholipid syndrome (APS) and are a part of its diagnostic criteria.
8 Δεκ 2023 · In this review, we present 3 patients with aPL and/or APS who highlight treatment dilemmas, and we discuss background information that may help guide clinical judgment in developing individualized treatment plans for patients with these enigmatic antibodies.
